90
Participants
Start Date
May 13, 2014
Primary Completion Date
January 24, 2019
Study Completion Date
January 24, 2019
Mirtazapine 15 MG Oral Tablet
The intervention will be a 15mg of mirtazapine oral tablet given to participants prior to their treatment scan and assessments. In order to ensure that biases or social desirability do not contaminate baseline assessments, all participants will also be given a tablet consisting of dextrose in gelatin prior to their baseline scan and assessment.
Virginia Commonwealth University, Richmond
The University of Texas Medical Branch, Galveston
OTHER
National Institute on Drug Abuse (NIDA)
NIH
Virginia Commonwealth University
OTHER